Survival Disparities in US Black Compared to White Women with Hormone Receptor Positive-HER2 Negative Breast Cancer-Reference-Cited by-同舟云学术

Survival Disparities in US Black Compared to White Women with Hormone Receptor Positive-HER2 Negative Breast Cancer

Published:2023-02-07 Issue:4 Volume:20 Page:2903
ISSN:1660-4601
Container-title:International Journal of Environmental Research and Public Health
language:en
Short-container-title:IJERPH

Author:

Lovejoy Leann A.¹,Shriver Craig D.²³^ORCID,Haricharan Svasti⁴,Ellsworth Rachel E.²⁵^ORCID

Affiliation:

1. Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA 15963, USA

2. Murtha Cancer Center/Research Program, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, MD 20889, USA

3. Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20889, USA

4. Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA

5. Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD 20817, USA

Abstract

Black women in the US have significantly higher breast cancer mortality than White women. Within biomarker-defined tumor subtypes, disparate outcomes seem to be limited to women with hormone receptor positive and HER2 negative (HR+/HER2−) breast cancer, a subtype usually associated with favorable prognosis. In this review, we present data from an array of studies that demonstrate significantly higher mortality in Black compared to White women with HR+/HER2-breast cancer and contrast these data to studies from integrated healthcare systems that failed to find survival differences. Then, we describe factors, both biological and non-biological, that may contribute to disparate survival in Black women.

Funder

Uniformed Services University of the Health Sciences

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Link

https://www.mdpi.com/1660-4601/20/4/2903/pdf

Reference82 articles.

1. American Cancer Society (2022). Cancer Facts and Figures 2022, American Cancer Society.

2. American Cancer Society (2022). Cancer Facts & Figures for African American/Black People 2022–2024, American Cancer Society.

3. American Cancer Society (2019). Breast Cancer Facts and Figure 2019 and Figure 2020, American Cancer Society.

4. Ma, H., Lu, Y., Malone, K.E., Marchbanks, P.A., Deapen, D.M., Spirtas, R., Burkman, R.T., Strom, B.L., A McDonald, J., and Folger, S.G. (2013). Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status. BMC Cancer, 13.

5. Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study;Cole;Clin. Cancer Res.,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temporal Association Rule Mining: Race-Based Patterns of Treatment-Adverse Events in Breast Cancer Patients Using SEER–Medicare Dataset;Biomedicines;2024-05-29

2. Early Stage Breast Cancer: Does Histologic Subtype (Ductal vs. Lobular) Impact 5 Year Overall Survival?;Cancers;2024-04-15

3. The role of cultural competency training to address health disparities in surgical settings;British Medical Bulletin;2024-03-11

4. Disparities in Hormone Receptor-Positive Breast Cancer;Current Breast Cancer Reports;2024-02-03

5. Considerations in Narrowing the Breast Cancer Mortality Gap Between Black and White Women;JAMA Oncology;2023-12-01